Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/91709
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Type: Journal article
Title: The use of dexmedetomidine as an adjuvant to benzodiazepine-based therapy to decrease the severity of delirium in alcohol withdrawal in adult intensive care unit patients: a systematic review protocol
Author: Dabrow Woods, A.
Giometti, R.
Weeks, S.
Citation: JBI Database of Systematic Reviews and Implementation Reports, 2014; 12(1):74-89
Publisher: Joanna Briggs Institute
Issue Date: 2014
ISSN: 2202-4433
2202-4433
Statement of
Responsibility: 
Anne Dabrow Woods, Renee Giometti, Susan Weeks
Abstract: Review question/objective - In adult intensive care unit patients experiencing alcohol withdrawal, does the use of dexmedetomidine as an adjuvant to benzodiazepine-based therapy decrease delirium severity more effectively than benzodiazepine-based therapy alone? The objective of the systematic review is to examine the best available evidence of the clinical effectiveness of dexmedetomidine as an adjuvant to benzodiazepine-based therapy versus benzodiazepine-based therapy alone, in decreasing delirium severity associated with alcohol withdrawal in adult intensive care unit patients over the age of 18 years.
Keywords: alcohol withdrawal syndrome; benzodiazepine-based therapy; delirium; dexmedetomidine; intensive care unit
Rights: Copyright status unknown
RMID: 0030024518
DOI: 10.11124/jbisrir-2014-1285
Appears in Collections:Translational Health Science publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.